Hypertension in Response to Chronic Reductions in Uterine Perfusion in Pregnant Rats Effect of Tumor Necrosis Factor-α Blockade

被引:133
作者
LaMarca, Babbette [1 ]
Speed, Josh [1 ]
Fournier, Lillian [1 ]
Babcock, Sara A. [1 ]
Berry, Hunter [1 ]
Cockrell, Kathy [1 ]
Granger, Joey P. [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Ctr Excellence Cardiovasc Renal Res, Jackson, MS 39216 USA
基金
美国国家卫生研究院;
关键词
hypertension; pregnancy; inflammation; cytokines; endothelial activation;
D O I
10.1161/HYPERTENSIONAHA.108.120881
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Reductions in uterine perfusion pressure (RUPP) in pregnant rats is associated with increased tumor necrosis factor-alpha (TNF-alpha). This study was designed to determine the role of endogenous TNF-alpha in mediating changes in arterial pressure and endothelin-1 (ET-1) in RUPP rats. To achieve this goal we examined the effect of RUPP in the presence and absence of a TNF-alpha-soluble receptor, etanerecept (0.4 mg/kg). Mean arterial pressure increased from 102 +/- 1 mm Hg in normal pregnant (NP) rats to 134 +/- 3 mm Hg (P < 0.05) in RUPP rats. Serum TNF-alpha increased to 40 +/- 7.6 pg/mL in RUPP rats (n=24) versus 14.8 +/- 3.3 pg/mL (n=16; P < 0.05) in NP rats. Administration of etanerecept decreased TNF-alpha in RUPP rats (n=20) to 17.2 +/- 3 pg/mL and mean arterial pressure to 118 +/- 2 mm Hg (P < 0.05). Tissue ET-1 decreased in etanerecept-treated RUPP rats compared with control RUPP rats. The direct effect of TNF-alpha blockade on endothelial activation in response to placental ischemia was examined in human umbilical vein endothelial cells. ET-1 secreted from human umbilical vein endothelial cells treated with RUPP serum was 59.2 + 16 pg/mg and decreased when etanerecept was added to the medium with RUPP serum (7.60 +/- 0.77 pg/mg), as well as in response to serum from etanerecept-treated RUPP rats (7.30 +/- 0.55 pg/mg; P < 0.001). ET-1 secreted from human umbilical vein endothelial cells was 15.6 +/- 2 pg/mg when treated with NP serum. These data support the hypothesis that endogenous TNF-alpha is an important stimulus for ET-1 in response to placental ischemia and is important in mediating endothelial cell activation and hypertension during pregnancy. (Hypertension. 2008;52:1161-1167.)
引用
收藏
页码:1161 / 1167
页数:7
相关论文
共 29 条
[1]  
Agirbasli M, 2006, CLIN EXP RHEUMATOL, V24, P580
[2]   Endothelin type A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure [J].
Alexander, BT ;
Rinewalt, AN ;
Cockrell, KL ;
Massey, MB ;
Bennett, WA ;
Granger, JP .
HYPERTENSION, 2001, 37 (02) :485-489
[3]   Chronic tumor necrosis factor-α inhibition enhances NO modulation of vascular function in estrogen-deficient rats [J].
Arenas, IA ;
Armstrong, SJ ;
Xu, Y ;
Davidge, ST .
HYPERTENSION, 2005, 46 (01) :76-81
[4]  
Ashworth JR, 1997, J SOC GYNECOL INVEST, V4, P71
[5]  
August Phyllis, 1995, P2407
[6]   Hypoxia stimulates cytokine production by villous explants from the human placenta [J].
Benyo, DF ;
Miles, TM ;
Conrad, KP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) :1582-1588
[7]  
Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240
[8]   TNF-α inhibition reduces renal injury in DOCA-salt hypertensive rats [J].
Elmarakby, Ahmed A. ;
Quigley, Jeffrey E. ;
Imig, John D. ;
Pollock, Jennifer S. ;
Pollock, David M. .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2008, 294 (01) :R76-R83
[9]   Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure [J].
Fichtlscherer, S ;
Rössig, L ;
Breuer, S ;
Vasa, M ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2001, 104 (25) :3023-3025
[10]  
Fisher S, 1998, CHESLEYS HYPERTENSIV, P377